Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

Senior Appointments

30 Mar 2010 12:37

RNS Number : 4219J
W.H. Ireland Group PLC
30 March 2010
 



WH Ireland Group Plc

 

Appointment of New Heads of Institutional Sales/Trading and Corporate Finance

 

WH Ireland Group plc (AIM:WHI), the financial services group, is delighted to announce two senior appointments to lead its Institutional Sales/Trading and Corporate Finance operations. Both will be joining in the week commencing 12 April 2010.

 

Russell Hooper joins as Head of Institutional Sales/Trading and will be responsible for coordinating the Group's institutional stockbroking business. Previously, Russell has been Head of European Institutional Client Sales Trading and also Head of Pan European Hedge Fund Sales Trading at Merrill Lynch where he spent 15 years in the Institutional Equities division. He graduated in Materials Engineering from Cardiff University. His interests include cricket, rugby (Welsh) and cycling.

 

Chris Fielding joins as Head of Corporate Finance, bringing with him over 20 years' experience in corporate finance as a small/mid cap specialist. Since 2005, Chris has worked at Arden Partners, having previously spent eleven years at Hoare Govett, where he was a director of Corporate Finance. He qualified as a chartered accountant with Price Waterhouse. Chris will be based in the Group's London office and will lead the continued expansion of the corporate finance business. Chris' interests and hobbies include rugby (English), skiing, classic cars, travel and walking.

 

The WH Ireland team already has significant depth of experience and strong regional coverage through John Wakefield (Bristol), Dan Bate (Manchester), James Joyce (London) and their respective teams, supported by the Group's award-winning research team, based in Leeds, headed by Matthew Davis. In line with the Group's strategy, these appointments will further enhance WH Ireland's institutional sales and corporate finance offering.

 

Commenting on the appointments, Richard Ford (CEO) said:

 

"We are delighted to have secured the services of two top calibre individuals both of whom bring substantial skill and experience to the firm. These appointments come at a time when we are seeing a significant uplift in client demand for our corporate stockbroking services where we are looking to build our already strong position in the market. Russell and Chris will continue to drive our business forward and complement our existing Securities business both in London and through our principal regional offices in Manchester, Leeds, Birmingham and Bristol."

 

John Wakefield commented:

 

"The two appointments continue the work already in place to address the aspirations of our corporate client base to gain wider access to sources of capital and to benefit from best of breed advice in our core small/mid cap market."

 

Matthew Davis (Head of Institutional Research) said of the appointments:

 

"Both Chris and Russell bring significant experience, further enhancing WH Ireland's distribution capability, both corporately and institutionally."

 

30 March 2010

 

Enquiries:

 

WH Ireland Tel: 020 7220 1666

Richard Ford

 

Biddicks (Financial PR to WH Ireland) Tel: 020 7448 1000

Zoe Biddick

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFMGFFMGDGGZM
Date   Source Headline
21st May 20107:00 amRNSBoard Changes
22nd Apr 201012:48 pmRNSResult of AGM
22nd Apr 201012:00 pmRNSAGM Statement
13th Apr 20108:04 amRNSDirector/PDMR Shareholding
8th Apr 20102:43 pmRNSDirector/PDMR Shareholding
7th Apr 20103:27 pmRNSDirector/PDMR Shareholding
30th Mar 201012:47 pmRNSNotice of AGM
30th Mar 201012:37 pmRNSSenior Appointments
29th Mar 20103:03 pmRNSDirector/PDMR Shareholding
15th Mar 20109:18 amRNSDirector/PDMR Shareholding
8th Mar 20104:25 pmRNSDirector/PDMR Shareholding Replacement
8th Mar 20103:58 pmRNSDirector/PDMR Shareholding
4th Mar 20103:48 pmRNSDirector/PDMR Shareholding
2nd Mar 20107:00 amRNSPreliminary Results
1st Feb 201012:19 pmRNSHolding(s) in Company
22nd Jan 20108:00 amRNSHolding(s) in Company
11th Jan 20103:37 pmRNSDirectorate Change
25th Nov 20093:10 pmRNSHolding(s) in Company
25th Nov 20092:49 pmRNSHolding(s) in Company
25th Nov 20092:20 pmRNSDirector/PDMR Shareholding
6th Nov 20097:00 amRNSPartial Disposal of Australian Subsidiary
9th Oct 20095:01 pmRNSHolding(s) in Company - Replacement
9th Oct 20094:28 pmRNSHolding(s) in Company - Amendment
28th Sep 200910:49 amRNSHolding(s) in Company
18th Sep 20093:17 pmRNSHolding(s) in Company
10th Sep 20097:00 amRNSNew Head of Wealth Management Joins with Team
17th Aug 20097:00 amRNSHalf Yearly Report
1st Jul 20097:00 amRNSDirectorate Change
10th Jun 20092:00 pmRNSHolding(s) in Company
1st Jun 20097:00 amRNSTotal Voting Rights
29th May 200912:00 pmRNSHolding(s) in Company
26th May 20094:02 pmRNSHolding(s) in Company
22nd May 20093:04 pmRNSHolding(s) in Company
22nd May 20093:03 pmRNSHolding(s) in Company
21st May 20094:20 pmRNSHolding(s) in Company
21st May 20094:18 pmRNSHolding(s) in Company
21st May 200910:21 amRNSExercise of Share Options
21st May 20099:28 amRNSDirector/PDMR Shareholding
20th May 20099:17 amRNSHolding(s) in Company
20th May 20099:04 amRNSHolding(s) in Company
19th May 20094:15 pmRNSDirectorate Change
15th May 20098:13 amRNSDirector/PDMR Shareholding
5th May 20092:40 pmRNSDirector/PDMR Shareholding
5th May 200911:25 amRNSAIM Rule 20
5th May 20097:00 amRNSHolding(s) in Company
1st May 20094:40 pmRNSRe. Unauthorised Dealings
29th Apr 200912:41 pmRNSResult of AGM
29th Apr 200911:16 amRNSAGM Statement
24th Apr 20097:15 amRNSRe Suspension of Directors
2nd Apr 20093:27 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.